van de Kar NCAJ - Search Results

1

COVID-19 vaccination and Atypical hemolytic uremic syndrome.

Bouwmeester RN, Bormans EMG, Duineveld C, van Zuilen AD, van de Logt AE, Wetzels JFM, van de Kar NCAJ. Bouwmeester RN, et al. Among authors: van de kar ncaj, van zuilen ad, van de logt ae. Front Immunol. 2022 Dec 1;13:1056153. doi: 10.3389/fimmu.2022.1056153. eCollection 2022. Front Immunol. 2022. PMID: 36531998 Free PMC article.

2

Disease burden in The Netherlands due to infections with Shiga toxin-producing Escherichia coli O157.

Havelaar AH, Van Duynhoven YT, Nauta MJ, Bouwknegt M, Heuvelink AE, De Wit GA, Nieuwenhuizen MG, van de Kar NC. Havelaar AH, et al. Epidemiol Infect. 2004 Jun;132(3):467-84. doi: 10.1017/s0950268804001979. Epidemiol Infect. 2004. PMID: 15188716 Free PMC article.

3

[From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].

Schiphorst RH, van de Kar NC, van den Heuvel LP. Schiphorst RH, et al. Ned Tijdschr Geneeskd. 2003 Dec 6;147(49):2422-4. Ned Tijdschr Geneeskd. 2003. PMID: 14694551 Review. Dutch.

4

Tumor necrosis factor and interleukin 1 induce expression of the glycolipid verotoxin receptor in human endothelial cells. Implications for the pathogenesis of the haemolytic uraemic syndrome.

Van de Kar NC, Monnens LA, Van Hinsbergh VW. Van de Kar NC, et al. Behring Inst Mitt. 1993 Aug;(92):202-9. Behring Inst Mitt. 1993. PMID: 8250811 Review.

5

Refractory severe intestinal vasculitis due to Henoch-Schönlein purpura: successful treatment with plasmapheresis.

Wortmann SB, Fiselier TJ, Van De Kar NC, Aarts RA, Warris A, Draaisma JM. Wortmann SB, et al. Acta Paediatr. 2006 May;95(5):622-3. doi: 10.1080/08035250500509180. Acta Paediatr. 2006. PMID: 16825146 No abstract available.

6

Plasma cytokine levels in hemolytic uremic syndrome.

van de Kar NC, Sauerwein RW, Demacker PN, Grau GE, van Hinsbergh VW, Monnens LA. van de Kar NC, et al. Nephron. 1995;71(3):309-13. doi: 10.1159/000188737. Nephron. 1995. PMID: 8569980

7

A missense mutation in factor I (IF) predisposes to atypical haemolytic uraemic syndrome.

Geelen J, van den Dries K, Roos A, van de Kar N, de Kat Angelino C, Klasen I, Monnens L, van den Heuvel L. Geelen J, et al. Pediatr Nephrol. 2007 Mar;22(3):371-5. doi: 10.1007/s00467-006-0320-2. Epub 2006 Nov 15. Pediatr Nephrol. 2007. PMID: 17106690

8

Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.

Peters HP, van de Kar NC, Wetzels JF. Peters HP, et al. Neth J Med. 2008 Nov;66(10):408-15. Neth J Med. 2008. PMID: 19011266 Free article.

9

A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome.

Westra D, Wetzels JF, Volokhina EB, van den Heuvel LP, van de Kar NC. Westra D, et al. Neth J Med. 2012 Apr;70(3):121-9. Neth J Med. 2012. PMID: 22516576 Free article. Review.

10

Living kidney transplantation in adult patients with atypical haemolytic uraemic syndrome.

Verhave JC, Westra D, van Hamersvelt HW, van Helden M, van de Kar NC, Wetzels JF. Verhave JC, et al. Neth J Med. 2013 Sep;71(7):342-7. Neth J Med. 2013. PMID: 24038559 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page